OUR MISSION
PHASE ONE is a Los Angeles-based nonprofit dedicated to supporting ground-breaking Phase I + II cancer clinical trials, innovative education and treatment programs, and forward-thinking leaders in the scientific and medical community.
Every cancer treatment starts with a Phase I clinical trial.
More trials lead to:
MORE HOPE at diagnosis.
MORE OPTIONS for treatment.
MORE LIFE.
WHAT IS A PHASE I CLINICAL TRIAL?
A Phase I clinical trial tests the safety, side effects, best dose, and timing of a new treatment. It is the first step in testing a new treatment in humans, and usually includes only a small number of patients. Phase I trials are also required when testing a new combination of previously approved drugs.
PHASE ONE Grantee Dr. Araz Marachelian at her research lab at Children's Hospital Los Angeles.
WHY WE DO WHAT WE DO
1 in 5 people will face the life-altering words: 'You have cancer.'
But there is hope. By investing in Phase I clinical trials, we can help move potentially life-saving treatments from the lab into everyday patient care.
PHASE ONE supports the best ideas and most innovative research at its earliest stages across all cancer types– leading to better treatment options, improved quality of life, and our ultimate goal: finding cures!
Founder, Alberto Valner, speaks about his personal experience with cancer.
Board Member, Mieke Neumann, shares why she believes in clinical trials.
Founding member, Mark Freeman, is passionate about giving back.
OUR IMPACT
PHASE ONE has provided 58+ grants for research in 28 different types of cancer– including types that are rare and underfunded.
PHASE ONE’s investment of $24 million has resulted in over $92 million in additional major funding for our grant recipients.
PHASE ONE has assisted with bringing 5 life-saving drugs to market and more approved treatments on the horizon.